Showing results (561-570 of 689) with videos related to
Sort By:
Pageof 69
Journal of Neuro-Oncology|January 5, 2000
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumorsK P Papadopoulos, C Balmaceda, M Fetell, et al.Circulation. Arrhythmia and Electrophysiology|January 13, 2017
Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)Mark S Link, Robert P Giugliano, Christian T Ruff, et al.Circulation|February 6, 2004
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trialMarc S Sabatine, David A Morrow, Robert P Giugliano, et al.Journal of the American Heart Association|October 30, 2018
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 TrialChristina L Fanola, Christian T Ruff, Sabina A Murphy, et al.Lancet (London, England)|April 2, 2008
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trialStephen D Wiviott, Eugene Braunwald, Carolyn H McCabe, et al.The American Journal of Cardiology|January 7, 1998
Angioplasty guidewire velocity: a new simple method to calculate absolute coronary blood velocity and flowC M Gibson, J T Dodge, M Goel, et al.Journal of the American Heart Association|July 2, 2017
Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 TrialAlon Eisen, Christian T Ruff, Eugene Braunwald, et al.Circulation|November 19, 2014
Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrateHamim Zahir, Karen S Brown, Alexander G Vandell, et al.European Heart Journal|November 1, 2001
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarctionJ Llevadot, R P Giugliano, E M Antman, et al.European Heart Journal. Cardiovascular Pharmacotherapy|November 6, 2019
Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trialAndré M Nicolau, Ramon Corbalan, Jose C Nicolau, et al.Pageof 69